EP0932406A4 - Methodes de traitement ou de prevention de la cystite interstitielle - Google Patents

Methodes de traitement ou de prevention de la cystite interstitielle

Info

Publication number
EP0932406A4
EP0932406A4 EP97908927A EP97908927A EP0932406A4 EP 0932406 A4 EP0932406 A4 EP 0932406A4 EP 97908927 A EP97908927 A EP 97908927A EP 97908927 A EP97908927 A EP 97908927A EP 0932406 A4 EP0932406 A4 EP 0932406A4
Authority
EP
European Patent Office
Prior art keywords
treating
methods
interstitial cystitis
preventing interstitial
preventing
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
EP97908927A
Other languages
German (de)
English (en)
Other versions
EP0932406A1 (fr
Inventor
Smriti Iyengar
Mark A Muhlhauser
Karl B Thor
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Eli Lilly and Co
Original Assignee
Eli Lilly and Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Eli Lilly and Co filed Critical Eli Lilly and Co
Publication of EP0932406A1 publication Critical patent/EP0932406A1/fr
Publication of EP0932406A4 publication Critical patent/EP0932406A4/fr
Withdrawn legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D209/02—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
    • C07D209/04—Indoles; Hydrogenated indoles
    • C07D209/10—Indoles; Hydrogenated indoles with substituted hydrocarbon radicals attached to carbon atoms of the hetero ring
    • C07D209/14—Radicals substituted by nitrogen atoms, not forming part of a nitro radical
    • C07D209/16—Tryptamines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445—Non condensed piperidines, e.g. piperocaine
    • A61K31/4523—Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems
    • A61K31/454—Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems containing a five-membered ring with nitrogen as a ring hetero atom, e.g. pimozide, domperidone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445—Non condensed piperidines, e.g. piperocaine
    • A61K31/4523—Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems
    • A61K31/4545—Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems containing a six-membered ring with nitrogen as a ring hetero atom, e.g. pipamperone, anabasine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/496—Non-condensed piperazines containing further heterocyclic rings, e.g. rifampin, thiothixene or sparfloxacin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/02—Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D209/02—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
    • C07D209/04—Indoles; Hydrogenated indoles
    • C07D209/10—Indoles; Hydrogenated indoles with substituted hydrocarbon radicals attached to carbon atoms of the hetero ring
    • C07D209/14—Radicals substituted by nitrogen atoms, not forming part of a nitro radical

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Epidemiology (AREA)
  • Urology & Nephrology (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Indole Compounds (AREA)
EP97908927A 1996-03-11 1997-03-07 Methodes de traitement ou de prevention de la cystite interstitielle Withdrawn EP0932406A4 (fr)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US1313096P 1996-03-11 1996-03-11
US613130P 1996-03-11
PCT/US1997/003555 WO1997033583A1 (fr) 1996-03-11 1997-03-07 Methodes de traitement ou de prevention de la cystite interstitielle

Publications (2)

Publication Number Publication Date
EP0932406A1 EP0932406A1 (fr) 1999-08-04
EP0932406A4 true EP0932406A4 (fr) 2000-07-05

Family

ID=21758466

Family Applications (1)

Application Number Title Priority Date Filing Date
EP97908927A Withdrawn EP0932406A4 (fr) 1996-03-11 1997-03-07 Methodes de traitement ou de prevention de la cystite interstitielle

Country Status (5)

Country Link
EP (1) EP0932406A4 (fr)
JP (1) JP2000506527A (fr)
AU (1) AU2071497A (fr)
CA (1) CA2247822A1 (fr)
WO (1) WO1997033583A1 (fr)

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1996001819A1 (fr) * 1994-07-12 1996-01-25 Eli Lilly And Company Antagonistes heterocycliques du recepteur de tachykinine

Non-Patent Citations (2)

* Cited by examiner, † Cited by third party
Title
No further relevant documents disclosed *
See also references of WO9733583A1 *

Also Published As

Publication number Publication date
CA2247822A1 (fr) 1997-09-18
JP2000506527A (ja) 2000-05-30
AU2071497A (en) 1997-10-01
EP0932406A1 (fr) 1999-08-04
WO1997033583A1 (fr) 1997-09-18

Similar Documents

Publication Publication Date Title
ZA965088B (en) Methods of preventing or treating allergles
ZA977564B (en) Method of treatment
GB9824436D0 (en) Methods of treatment
IL134718A0 (en) Treatment of conduct disorder
AU2207897A (en) Methods of treating or preventing interstitial cystitis
EP0795035A4 (fr) Traitement des peaux
GB9715295D0 (en) Novel method of treatment
EP0711168A4 (fr) Procedes de traitement de l'apoptose et d'etats associes
GB9712866D0 (en) Novel method of treatment
HUP9902884A3 (en) Use of duloxetine for treating or preventing interstitial cystitis
GB9707693D0 (en) Novel method of treatment
GB9715298D0 (en) Novel method of treatment
GB9715306D0 (en) Novel method of treatment
ZA971958B (en) Treatment of cocoa
ZA973988B (en) Method of treatment
GB9618341D0 (en) Method of treatment
EP0932406A4 (fr) Methodes de traitement ou de prevention de la cystite interstitielle
GB9317943D0 (en) Treatment of laminitis
GB9415902D0 (en) Method of treatment
GB9407335D0 (en) Method of treatment
GB9602404D0 (en) Methods of treatment
GB9414652D0 (en) Method of treatment
GB9600888D0 (en) Method of treatment
GB9317989D0 (en) Treatment of laminitis
GB9701448D0 (en) Methods of treatment

Legal Events

Date Code Title Description
PUAI Public reference made under article 153(3) epc to a published international application that has entered the european phase

Free format text: ORIGINAL CODE: 0009012

17P Request for examination filed

Effective date: 19980909

AK Designated contracting states

Kind code of ref document: A1

Designated state(s): AT BE CH DE DK ES FI FR GB GR IE IT LI LU NL PT SE

A4 Supplementary search report drawn up and despatched

Effective date: 20000524

AK Designated contracting states

Kind code of ref document: A4

Designated state(s): AT BE CH DE DK ES FI FR GB GR IE IT LI LU NL PT SE

RIC1 Information provided on ipc code assigned before grant

Free format text: 7A 61K 31/445 A, 7C 07D 401/14 B, 7A 61K 31/495 B

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: THE APPLICATION IS DEEMED TO BE WITHDRAWN

17Q First examination report despatched

Effective date: 20030220

18D Application deemed to be withdrawn

Effective date: 20021001